Research Institute: Centre for Clinical Research, University of Queensland
Amount granted: $2 million
Year granted: 2012
This was the ACRF’s first grant to this research team at The Centre for Clinical Research (CCR). The CCR is based within the University of Queensland and supported by four health and research partners.
The funds were used for specialised equipment to study tumour localisation and analysis – specifically in glioma (brain tumours), prostate, ovarian and head and neck cancers.
The grant funded the purchase of PET/CT hybrid scanners alongside PET/MRI within a single research site, called the ACRF Molecular Oncology Translational Imaging Facility.
The facility has also provided a first-rate technology and scientific environment for training the next generation of oncology scientists.
Chief Investigator: Associate Professor Stephen Rose and Professors Andrew Boyd, Stuart Whittaker, Nicholas Fisk and Murray Mitchell.
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.